Antimicrobial Drug Resistance in Non-Typhoidal Salmonellas from Humans in England and Wales in 1999: Decrease in Multiple Resistance in Salmonella enterica Serotypes Typhimurium, Virchow, and Hadar
In 1999 the incidence of multiple drug resistance (to four or more antimicrobials) in non-typhoidal salmonellas from humans in England and Wales fell in isolations of Salmonella enterica serotypes Typhimurium, Virchow, and Hadar. This fall has been most noticeable in S . Typhimurium, where 59% of is...
Gespeichert in:
| Veröffentlicht in: | Microbial drug resistance (Larchmont, N.Y.) N.Y.), 2000, Vol.6 (4), p.319-325 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 325 |
|---|---|
| container_issue | 4 |
| container_start_page | 319 |
| container_title | Microbial drug resistance (Larchmont, N.Y.) |
| container_volume | 6 |
| creator | Threlfall, E J Ward, L R Skinner, J A Graham, A |
| description | In 1999 the incidence of multiple drug resistance (to four or more antimicrobials) in non-typhoidal salmonellas from humans in England and Wales fell in isolations of
Salmonella enterica
serotypes Typhimurium, Virchow, and Hadar. This fall has been most noticeable in
S
. Typhimurium, where 59% of isolates were multiresistant compared to 81% in 1996. The main reason for this has been a 75% decline in isolations of multiply-resistant
S
. Typhimurium definitive phage type (DT) 104 (MR DT104) since 1996. Nevertheless MR DT104 remains second to
S
. Enteritidis phage type 4 as the most common strain in cases of human salmonellosis in England and Wales. Multiple resistance has also remained high in
S
. Hadar, with 49% of isolates resistant to four drugs or more compared to 56% in 1996. Isolates with decreased sensitivity to ciprofloxacin (minimal inhibitory concentration: 0.25–1.0 μg/L) have increased in incidence in
S
. Enteritidis,
S
. Virchow, and
S
. Hadar; in
S
. Hadar 70% of isolates were resistant to ciprofloxacin at this level. It is hoped that Codes of Practice introduced by some pharmaceutical companies, governments, professional organisations, and others to combat the unnecessary prophylactic use of fluoroquinolones in animal husbandry will not result in a reduction in the incidence of resistance to ciprofloxacin in salmonella organisms causing infections in humans. |
| doi_str_mv | 10.1089/mdr.2000.6.319 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72556170</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>72556170</sourcerecordid><originalsourceid>FETCH-LOGICAL-c367t-95b792c79458b176add22371116e9a27683ca67b90d9c6e185314b29160a8a53</originalsourceid><addsrcrecordid>eNqFkcFu1DAQhiMEoqVw5Yh84tQEj53YMbeqLSxSAYmu4BhNHG9rZDtbOxHaB-S9cHZXqsSlB2us0Tf_jPQVxVugFdBWffBDrBiltBIVB_WsOAXFoWzrun2e_1SKUjBVnxSvUvqdsQYEf1mcADDJmIDT4u9FmKy3Oo69RUeu4nxHfphk04RBG2ID-TaGcr3b3o92yMAtOj8G4xwmsomjJ6vZY0gLeB3uHIaBLO8XOrNvglLqI7kyOhpM-7yvs5vs1pn_1jwGExMmE61GcmviOO22OWk5wPo52tmfk5826vvxz_l-0woHjK-LFxt0ybw51rNi_el6fbkqb75__nJ5cVNqLuRUqqaXimmp6qbtQQocBsa4BABhFDIpWq5RyF7RQWlhoG041D1TICi22PCz4v0hdhvHh9mkqfM26eXmYMY5dZI1jQBJnwRBtrzhkmewOoBZQErRbLpttB7jrgPaLYK7LLhbBHeiy4LzwLtj8tx7MzziR6MZqA_A0sYQnDW9idNTuf8AmcS0qg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17835373</pqid></control><display><type>article</type><title>Antimicrobial Drug Resistance in Non-Typhoidal Salmonellas from Humans in England and Wales in 1999: Decrease in Multiple Resistance in Salmonella enterica Serotypes Typhimurium, Virchow, and Hadar</title><source>Mary Ann Liebert Online Subscription</source><source>MEDLINE</source><creator>Threlfall, E J ; Ward, L R ; Skinner, J A ; Graham, A</creator><creatorcontrib>Threlfall, E J ; Ward, L R ; Skinner, J A ; Graham, A</creatorcontrib><description>In 1999 the incidence of multiple drug resistance (to four or more antimicrobials) in non-typhoidal salmonellas from humans in England and Wales fell in isolations of
Salmonella enterica
serotypes Typhimurium, Virchow, and Hadar. This fall has been most noticeable in
S
. Typhimurium, where 59% of isolates were multiresistant compared to 81% in 1996. The main reason for this has been a 75% decline in isolations of multiply-resistant
S
. Typhimurium definitive phage type (DT) 104 (MR DT104) since 1996. Nevertheless MR DT104 remains second to
S
. Enteritidis phage type 4 as the most common strain in cases of human salmonellosis in England and Wales. Multiple resistance has also remained high in
S
. Hadar, with 49% of isolates resistant to four drugs or more compared to 56% in 1996. Isolates with decreased sensitivity to ciprofloxacin (minimal inhibitory concentration: 0.25–1.0 μg/L) have increased in incidence in
S
. Enteritidis,
S
. Virchow, and
S
. Hadar; in
S
. Hadar 70% of isolates were resistant to ciprofloxacin at this level. It is hoped that Codes of Practice introduced by some pharmaceutical companies, governments, professional organisations, and others to combat the unnecessary prophylactic use of fluoroquinolones in animal husbandry will not result in a reduction in the incidence of resistance to ciprofloxacin in salmonella organisms causing infections in humans.</description><identifier>ISSN: 1076-6294</identifier><identifier>EISSN: 1931-8448</identifier><identifier>DOI: 10.1089/mdr.2000.6.319</identifier><identifier>PMID: 11272261</identifier><language>eng</language><publisher>United States</publisher><subject>Anti-Bacterial Agents - pharmacology ; Anti-Bacterial Agents - therapeutic use ; Anti-Infective Agents - pharmacology ; Anti-Infective Agents - therapeutic use ; Bacteriophage Typing ; British Isles ; Ciprofloxacin - pharmacology ; Ciprofloxacin - therapeutic use ; Drug Resistance, Microbial ; Drug Resistance, Multiple ; England ; Humans ; Salmonella enterica ; Salmonella enterica - classification ; Salmonella enterica - drug effects ; Salmonella enterica - isolation & purification ; Salmonella enteritidis - classification ; Salmonella enteritidis - drug effects ; Salmonella enteritidis - isolation & purification ; Salmonella Infections - drug therapy ; Salmonella Infections - microbiology ; Salmonella typhimurium - classification ; Salmonella typhimurium - drug effects ; Salmonella typhimurium - isolation & purification ; Serotyping ; Wales</subject><ispartof>Microbial drug resistance (Larchmont, N.Y.), 2000, Vol.6 (4), p.319-325</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c367t-95b792c79458b176add22371116e9a27683ca67b90d9c6e185314b29160a8a53</citedby><cites>FETCH-LOGICAL-c367t-95b792c79458b176add22371116e9a27683ca67b90d9c6e185314b29160a8a53</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.liebertpub.com/doi/epdf/10.1089/mdr.2000.6.319$$EPDF$$P50$$Gmaryannliebert$$H</linktopdf><linktohtml>$$Uhttps://www.liebertpub.com/doi/full/10.1089/mdr.2000.6.319$$EHTML$$P50$$Gmaryannliebert$$H</linktohtml><link.rule.ids>314,780,784,3042,4024,21723,27923,27924,27925,55291,55303</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11272261$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Threlfall, E J</creatorcontrib><creatorcontrib>Ward, L R</creatorcontrib><creatorcontrib>Skinner, J A</creatorcontrib><creatorcontrib>Graham, A</creatorcontrib><title>Antimicrobial Drug Resistance in Non-Typhoidal Salmonellas from Humans in England and Wales in 1999: Decrease in Multiple Resistance in Salmonella enterica Serotypes Typhimurium, Virchow, and Hadar</title><title>Microbial drug resistance (Larchmont, N.Y.)</title><addtitle>Microb Drug Resist</addtitle><description>In 1999 the incidence of multiple drug resistance (to four or more antimicrobials) in non-typhoidal salmonellas from humans in England and Wales fell in isolations of
Salmonella enterica
serotypes Typhimurium, Virchow, and Hadar. This fall has been most noticeable in
S
. Typhimurium, where 59% of isolates were multiresistant compared to 81% in 1996. The main reason for this has been a 75% decline in isolations of multiply-resistant
S
. Typhimurium definitive phage type (DT) 104 (MR DT104) since 1996. Nevertheless MR DT104 remains second to
S
. Enteritidis phage type 4 as the most common strain in cases of human salmonellosis in England and Wales. Multiple resistance has also remained high in
S
. Hadar, with 49% of isolates resistant to four drugs or more compared to 56% in 1996. Isolates with decreased sensitivity to ciprofloxacin (minimal inhibitory concentration: 0.25–1.0 μg/L) have increased in incidence in
S
. Enteritidis,
S
. Virchow, and
S
. Hadar; in
S
. Hadar 70% of isolates were resistant to ciprofloxacin at this level. It is hoped that Codes of Practice introduced by some pharmaceutical companies, governments, professional organisations, and others to combat the unnecessary prophylactic use of fluoroquinolones in animal husbandry will not result in a reduction in the incidence of resistance to ciprofloxacin in salmonella organisms causing infections in humans.</description><subject>Anti-Bacterial Agents - pharmacology</subject><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Anti-Infective Agents - pharmacology</subject><subject>Anti-Infective Agents - therapeutic use</subject><subject>Bacteriophage Typing</subject><subject>British Isles</subject><subject>Ciprofloxacin - pharmacology</subject><subject>Ciprofloxacin - therapeutic use</subject><subject>Drug Resistance, Microbial</subject><subject>Drug Resistance, Multiple</subject><subject>England</subject><subject>Humans</subject><subject>Salmonella enterica</subject><subject>Salmonella enterica - classification</subject><subject>Salmonella enterica - drug effects</subject><subject>Salmonella enterica - isolation & purification</subject><subject>Salmonella enteritidis - classification</subject><subject>Salmonella enteritidis - drug effects</subject><subject>Salmonella enteritidis - isolation & purification</subject><subject>Salmonella Infections - drug therapy</subject><subject>Salmonella Infections - microbiology</subject><subject>Salmonella typhimurium - classification</subject><subject>Salmonella typhimurium - drug effects</subject><subject>Salmonella typhimurium - isolation & purification</subject><subject>Serotyping</subject><subject>Wales</subject><issn>1076-6294</issn><issn>1931-8448</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkcFu1DAQhiMEoqVw5Yh84tQEj53YMbeqLSxSAYmu4BhNHG9rZDtbOxHaB-S9cHZXqsSlB2us0Tf_jPQVxVugFdBWffBDrBiltBIVB_WsOAXFoWzrun2e_1SKUjBVnxSvUvqdsQYEf1mcADDJmIDT4u9FmKy3Oo69RUeu4nxHfphk04RBG2ID-TaGcr3b3o92yMAtOj8G4xwmsomjJ6vZY0gLeB3uHIaBLO8XOrNvglLqI7kyOhpM-7yvs5vs1pn_1jwGExMmE61GcmviOO22OWk5wPo52tmfk5826vvxz_l-0woHjK-LFxt0ybw51rNi_el6fbkqb75__nJ5cVNqLuRUqqaXimmp6qbtQQocBsa4BABhFDIpWq5RyF7RQWlhoG041D1TICi22PCz4v0hdhvHh9mkqfM26eXmYMY5dZI1jQBJnwRBtrzhkmewOoBZQErRbLpttB7jrgPaLYK7LLhbBHeiy4LzwLtj8tx7MzziR6MZqA_A0sYQnDW9idNTuf8AmcS0qg</recordid><startdate>2000</startdate><enddate>2000</enddate><creator>Threlfall, E J</creator><creator>Ward, L R</creator><creator>Skinner, J A</creator><creator>Graham, A</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>C1K</scope><scope>7X8</scope></search><sort><creationdate>2000</creationdate><title>Antimicrobial Drug Resistance in Non-Typhoidal Salmonellas from Humans in England and Wales in 1999: Decrease in Multiple Resistance in Salmonella enterica Serotypes Typhimurium, Virchow, and Hadar</title><author>Threlfall, E J ; Ward, L R ; Skinner, J A ; Graham, A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c367t-95b792c79458b176add22371116e9a27683ca67b90d9c6e185314b29160a8a53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Anti-Bacterial Agents - pharmacology</topic><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Anti-Infective Agents - pharmacology</topic><topic>Anti-Infective Agents - therapeutic use</topic><topic>Bacteriophage Typing</topic><topic>British Isles</topic><topic>Ciprofloxacin - pharmacology</topic><topic>Ciprofloxacin - therapeutic use</topic><topic>Drug Resistance, Microbial</topic><topic>Drug Resistance, Multiple</topic><topic>England</topic><topic>Humans</topic><topic>Salmonella enterica</topic><topic>Salmonella enterica - classification</topic><topic>Salmonella enterica - drug effects</topic><topic>Salmonella enterica - isolation & purification</topic><topic>Salmonella enteritidis - classification</topic><topic>Salmonella enteritidis - drug effects</topic><topic>Salmonella enteritidis - isolation & purification</topic><topic>Salmonella Infections - drug therapy</topic><topic>Salmonella Infections - microbiology</topic><topic>Salmonella typhimurium - classification</topic><topic>Salmonella typhimurium - drug effects</topic><topic>Salmonella typhimurium - isolation & purification</topic><topic>Serotyping</topic><topic>Wales</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Threlfall, E J</creatorcontrib><creatorcontrib>Ward, L R</creatorcontrib><creatorcontrib>Skinner, J A</creatorcontrib><creatorcontrib>Graham, A</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Environmental Sciences and Pollution Management</collection><collection>MEDLINE - Academic</collection><jtitle>Microbial drug resistance (Larchmont, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Threlfall, E J</au><au>Ward, L R</au><au>Skinner, J A</au><au>Graham, A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Antimicrobial Drug Resistance in Non-Typhoidal Salmonellas from Humans in England and Wales in 1999: Decrease in Multiple Resistance in Salmonella enterica Serotypes Typhimurium, Virchow, and Hadar</atitle><jtitle>Microbial drug resistance (Larchmont, N.Y.)</jtitle><addtitle>Microb Drug Resist</addtitle><date>2000</date><risdate>2000</risdate><volume>6</volume><issue>4</issue><spage>319</spage><epage>325</epage><pages>319-325</pages><issn>1076-6294</issn><eissn>1931-8448</eissn><abstract>In 1999 the incidence of multiple drug resistance (to four or more antimicrobials) in non-typhoidal salmonellas from humans in England and Wales fell in isolations of
Salmonella enterica
serotypes Typhimurium, Virchow, and Hadar. This fall has been most noticeable in
S
. Typhimurium, where 59% of isolates were multiresistant compared to 81% in 1996. The main reason for this has been a 75% decline in isolations of multiply-resistant
S
. Typhimurium definitive phage type (DT) 104 (MR DT104) since 1996. Nevertheless MR DT104 remains second to
S
. Enteritidis phage type 4 as the most common strain in cases of human salmonellosis in England and Wales. Multiple resistance has also remained high in
S
. Hadar, with 49% of isolates resistant to four drugs or more compared to 56% in 1996. Isolates with decreased sensitivity to ciprofloxacin (minimal inhibitory concentration: 0.25–1.0 μg/L) have increased in incidence in
S
. Enteritidis,
S
. Virchow, and
S
. Hadar; in
S
. Hadar 70% of isolates were resistant to ciprofloxacin at this level. It is hoped that Codes of Practice introduced by some pharmaceutical companies, governments, professional organisations, and others to combat the unnecessary prophylactic use of fluoroquinolones in animal husbandry will not result in a reduction in the incidence of resistance to ciprofloxacin in salmonella organisms causing infections in humans.</abstract><cop>United States</cop><pmid>11272261</pmid><doi>10.1089/mdr.2000.6.319</doi><tpages>7</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1076-6294 |
| ispartof | Microbial drug resistance (Larchmont, N.Y.), 2000, Vol.6 (4), p.319-325 |
| issn | 1076-6294 1931-8448 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_72556170 |
| source | Mary Ann Liebert Online Subscription; MEDLINE |
| subjects | Anti-Bacterial Agents - pharmacology Anti-Bacterial Agents - therapeutic use Anti-Infective Agents - pharmacology Anti-Infective Agents - therapeutic use Bacteriophage Typing British Isles Ciprofloxacin - pharmacology Ciprofloxacin - therapeutic use Drug Resistance, Microbial Drug Resistance, Multiple England Humans Salmonella enterica Salmonella enterica - classification Salmonella enterica - drug effects Salmonella enterica - isolation & purification Salmonella enteritidis - classification Salmonella enteritidis - drug effects Salmonella enteritidis - isolation & purification Salmonella Infections - drug therapy Salmonella Infections - microbiology Salmonella typhimurium - classification Salmonella typhimurium - drug effects Salmonella typhimurium - isolation & purification Serotyping Wales |
| title | Antimicrobial Drug Resistance in Non-Typhoidal Salmonellas from Humans in England and Wales in 1999: Decrease in Multiple Resistance in Salmonella enterica Serotypes Typhimurium, Virchow, and Hadar |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T16%3A34%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Antimicrobial%20Drug%20Resistance%20in%20Non-Typhoidal%20Salmonellas%20from%20Humans%20in%20England%20and%20Wales%20in%201999:%20Decrease%20in%20Multiple%20Resistance%20in%20Salmonella%20enterica%20Serotypes%20Typhimurium,%20Virchow,%20and%20Hadar&rft.jtitle=Microbial%20drug%20resistance%20(Larchmont,%20N.Y.)&rft.au=Threlfall,%20E%20J&rft.date=2000&rft.volume=6&rft.issue=4&rft.spage=319&rft.epage=325&rft.pages=319-325&rft.issn=1076-6294&rft.eissn=1931-8448&rft_id=info:doi/10.1089/mdr.2000.6.319&rft_dat=%3Cproquest_cross%3E72556170%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17835373&rft_id=info:pmid/11272261&rfr_iscdi=true |